KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Gains from Investment Securities: 2012-2024

Historic Gains from Investment Securities for CareDx (CDNA) over the last 13 years, with Dec 2024 value amounting to $10.1 million.

  • CareDx's Gains from Investment Securities fell 49.23% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 78.51%. This contributed to the annual value of $10.1 million for FY2024, which is 229.91% up from last year.
  • According to the latest figures from FY2024, CareDx's Gains from Investment Securities is $10.1 million, which was up 229.91% from $3.1 million recorded in FY2023.
  • In the past 5 years, CareDx's Gains from Investment Securities registered a high of $18.1 million during FY2021, and its lowest value of $3.1 million during FY2023.
  • In the last 3 years, CareDx's Gains from Investment Securities had a median value of $5.9 million in 2022 and averaged $6.4 million.
  • In the last 5 years, CareDx's Gains from Investment Securities surged by 352.90% in 2020 and then plummeted by 67.16% in 2022.
  • Over the past 5 years, CareDx's Gains from Investment Securities (Yearly) stood at $4.5 million in 2020, then spiked by 298.87% to $18.1 million in 2021, then plummeted by 67.16% to $5.9 million in 2022, then tumbled by 48.44% to $3.1 million in 2023, then spiked by 229.91% to $10.1 million in 2024.